Australia's most trusted
source of pharma news
Posted 30 May 2025 AM
Off the back of Ledaga’s successful launch, Arrotex has been appointed Juniper Biologics' ANZ exclusive partner, with a new specialty sales team already established to support the commercialisation of an innovative range of therapies.
Under the agreement, Arrotex will assume comprehensive sales and marketing responsibilities for the Singapore headquartered company’s portfolio of products in Australia while Juniper Biologics will utilise Arrotex's platform, infrastructure, and operational capabilities.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.